These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8552575)
1. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Jimenez FJ; Burchette JL; Grichnik JM; Hitchcock MG Mod Pathol; 1995 Oct; 8(8):854-8. PubMed ID: 8552575 [TBL] [Abstract][Full Text] [Related]
2. Ber-EP4 antigen is a marker for a cell population related to the secondary hair germ. Ozawa M; Aiba S; Kurosawa M; Tagami H Exp Dermatol; 2004 Jul; 13(7):401-5. PubMed ID: 15217359 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation]. González-Guerra E; Requena L; Kutzner H Actas Dermosifiliogr; 2008; 99(6):456-63. PubMed ID: 18558053 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Tellechea O; Reis JP; Domingues JC; Baptista AP Am J Dermatopathol; 1993 Oct; 15(5):452-5. PubMed ID: 8238781 [TBL] [Abstract][Full Text] [Related]
8. [Contribution of monoclonal antibody D 47 in the study of sweat gland pathology]. Kanitakis J; Schmitt D; Thivolet J Ann Pathol; 1985; 5(1):19-27. PubMed ID: 2990499 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations. González-Guerra E; Kutzner H; Rutten A; Requena L Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111 [TBL] [Abstract][Full Text] [Related]
10. Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinoma. Kogut M; Toberer F; Enk AH; Hassel JC J Cutan Pathol; 2016 Apr; 43(4):367-71. PubMed ID: 26765054 [TBL] [Abstract][Full Text] [Related]
11. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection. Gill P; Naugler C; Abi Daoud MS Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953 [TBL] [Abstract][Full Text] [Related]
12. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083 [TBL] [Abstract][Full Text] [Related]
13. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms. Sellheyer K; Krahl D J Cutan Pathol; 2008 Apr; 35(4):366-72. PubMed ID: 18333896 [TBL] [Abstract][Full Text] [Related]
16. Divergent differentiation in endocrine and nonendocrine tumors of the skin. Foschini MP; Eusebi V Semin Diagn Pathol; 2000 May; 17(2):162-8. PubMed ID: 10839616 [TBL] [Abstract][Full Text] [Related]
17. Tubular adenoma of the skin with follicular and sebaceous differentiation: A report of two cases. Kazakov DV; Mukensnabl P; Michal M Am J Dermatopathol; 2006 Apr; 28(2):142-6. PubMed ID: 16625077 [TBL] [Abstract][Full Text] [Related]
18. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery. Katz KH; Helm KF; Billingsley EM; Maloney ME J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184 [TBL] [Abstract][Full Text] [Related]
19. Distribution of epithelial membrane antigen in eccrine poroma. Takanashi M; Urabe A; Nakayama J; Hori Y Dermatologica; 1991; 183(3):187-90. PubMed ID: 1720746 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical differentiation of basal cell epithelioma from cutaneous appendages using monoclonal anti-glycoprotein antibody TNKH1. Its application in Mohs' micrographic surgery. Setoyama M; Hashimoto K; Dinehart SM; Choi KC; Ishihara M; Predeteanu GS; Tronnier M; Pietruk T; Nakanishi T Cancer; 1990 Dec; 66(12):2533-40. PubMed ID: 2249196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]